Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
The iPhone 8 is set to hit the streets this fall, and all indications are it'll be the smash hit we've been expecting.
Of course, the Apple fans out there are excited, as we knew they would be. I'm fired up, too, but for an entirely different reason.
Now, it's not because of what the iPhone 8 is – the latest iteration of an outrageously popular and undeniably cool piece of personal tech…
And it's not for what the new iPhone represents – the 10th anniversary of "iEverything"…
Rather, it's because of what the iPhone 8 has…
Biometrics.
That's right: The iPhone 8 (and, in short order, nearly every smart device that hits the market) will have some extremely sophisticated biometric technology onboard, largely thanks to this company…
This Is a "Backdoor" to Every Big-Cap Mobile Maker
Fingerprint recognition, voice recognition, iris recognition, and facial recognition are just some of the biometric functions we'll come across more and more in our daily lives.
Fact is, we're already using them to some extent; the last generation of smartphones from Apple, Samsung, and LG, for instance, included fingerprint readers, and tens of millions of Americans are on a first-name basis with Siri, Alexa, and "OK Google."
All of these can keep your device safe, read you curated news, order you a pizza, or call you a Lyft.
As the list of indispensable devices gets "smarter," the demand for biometrics for security or device-input reasons is growing at an increasingly rapid rate.
In 2015, the biometrics industry was worth roughly $10 billion. But according to Grand View Research, by 2025, biometrics promises to be a $60 billion industry – a 600% increase in just eight years.
And that's conservative. A recent report from Research and Markets projects a compound annual growth rate (CAGR) of 23% over that same time frame, with the industry hitting $70 billion by 2025.
The difference alone between these two estimates is about what the entire biometrics market was worth barely three years ago.
This is becoming the must-have tech.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.
From a contrarian point of view, why is it okay to buy a stock when it is 25% off fare value verses, sell when a stock hits a 25% stop Price?
I think you meant "fair value". And who doesn't love a bargain?
I am getting a news letter from Nova already.